Research progress of the competing endogenous RNA in primary hepatocellular
carcinoma

doi:10.3760/cma.j.issn.1673422X.2017.03.019

Abstract

Abstract: Competing endogenous RNAs (ceRNAs) transcripts can communicate with microRNAs (miRNAs) through competitively binding the common miRNA response elements (MREs), which remove or decrease the repression of target genes of miRNAs. The present studies indicate that a large amount of genes, serving as ceRNAs, can promote or inhibit the occurrence of liver cancer by competing the binding site of same genes that can promote or suppress tumorigenesis．

Key words: Liver neoplasms, MicroRNAs, Long noncoding RNA

He Xiaoqin, Xu Ximing. Research progress of the competing endogenous RNA in primary hepatocellular carcinoma[J]. Journal of International Oncology, 2017, 44(3): 231-234.

References

［1］ Casane D, Fumey J, Laurenti P. ENCODE apophenia or a panglossian analysis of the human genome［J］. Med Sci (Paris), 2015, 31(6/7): 680-686. DOI: 10.1051/medsci/20153106023. ［2］ Veneziano D, Di Bella S, Nigita G, et al. Noncoding RNA: current deep sequencing data analysis approaches and challenges［J］. Hum Mutat, 2016, 37（12）： 1283-1298. DOI: 10.1002/humu.23066. ［3］ Tay Y, Rinn J, Pandolfi PP. The multilayered complexity of ceRNA crosstalk and competition［J］. Nature, 2014, 505(7483): 344-352. DOI: 10.1038/nature12986. ［4］ Zhang Y, Xu Y, Feng L, et al. Comprehensive characterization of lncRNAmRNA related ceRNA network across 12 major cancers［J］. Oncotarget, 2016, 7（39）： 64148-64167. DOI: 10.18632/oncotarget.11637. ［5］ Liu XH, Sun M, Nie FQ, et al. Lnc RNA HOTAIR functions as a competing endogenous RNA to regulate HER2 expression by sponging miR3313p in gastric cancer［J］. Mol Cancer, 2014, 13(1): 92. DOI: 10.1186/14764598 1392. ［6］ Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015［J ］. CA Cancer J Clin, 2016, 66(2): 115-132. DOI: 10.3322/caac.21338. ［7］ Yang C, Wu D, Gao L, et al. Competing endogenous RNA networks in human cancer: hypothesis, validation, and perspectives［J］. Oncotarget, 2016, 7(12): 13479-13490. DOI: 10.18632/oncotarget.7266. ［8］ Cao C, Sun J, Zhang D, et al. The long intergenic noncoding RNA UFC1, a target of microRNA 34a, interacts with the mRNA stabilizing protein HuR to increase levels of βcatenin in HCC cells［J］. Gastroenterology, 2015, 148(2): 415-426.e18. DOI: 10.1053/j.gastro.2014.10.012. ［9］ Yoo S, Kim HH, Kim P, et al. A HuDZBP1 ribonucleoprotein complex localizes GAP43 mRNA into axons through its 3′ untranslated region AUrich regulatory element［J］. J Neurochem, 2013, 126(6): 792-804. DOI: 10.1111/jnc.12266. ［10］ An Y, Furber KL, Ji S. Pseudogenes regulate parental gene expression via ceRNA network［J］. J Cell Mol Med, 2017, 21（1）： 185-192. DOI: 10.1111/jcmm.12952. ［11］ Thomson DW, Dinger ME. Endogenous microRNA sponges: evidence and controversy［J］. Nat Rev Genet, 2016, 17(5): 272-283. DOI: 10.1038/nrg.2016.20. ［12］ Kluiver J, SlezakProchazka I, SmigielskaCzepiel K, et al. Generation of miRNA sponge constructs［J］. Methods, 2012, 58(2): 113-117. DOI: 10.1016/j.ymeth.2012.07.019. ［13］ Tay FC, Lim JK, Zhu H, et al. Using artificial microRNA sponges to achieve microRNA lossoffunction in cancer cells［J］. Adv Drug Deliv Rev, 2015, 81(81): 117-127. DOI: 10.1016/j.addr.2014.05.010. ［14］ Giza DE, Vasilescu C, Calin GA. MicroRNAs and ceRNAs: therapeutic implications of RNA networks［J］. Expert Opin Biol Ther, 2014, 14(9): 1285 -1293. DOI: 10.1517/14712598.2014.920812. ［15］ Karreth FA, Pandolfi PP. ceRNA crosstalk in cancer: when cebling rivalries go awry［J］. Cancer Discov, 2013, 3(10): 1113-1121. DOI: 10.1158/21598290.CD130202. ［16］ Dong P, Xiong Y, Watari H, et al. MiR137 and miR34a directly target Snail and inhibit EMT, invasion and sphereforming ability of ovarian cancer cells［J］. J Exp Clin Cancer Res, 2016, 35(1): 132. DOI: 10.1186/s130460160415y. ［17］ Dang Y, Luo D, Rong M, et al. Underexpression of miR34a in hepatocellular carcinoma and its contribution towards enhancement of proliferating inhibitory effects of agents targeting cMET［J］. PLoS One, 2013, 8(4): e61054. DOI: 10.1371/journal.pone.0061054. ［18］ ArriagaCanon C, FonsecaGuzmán Y, ValdesQuezada C, et al. A long noncoding RNA promotes full activation of adult gene expression in the chicken αglobin domain［J］. Epigenetics, 2014, 9(1): 173-181. DOI: 10.4161/epi.27030. ［19］ Gutschner T, Diederichs S. The hallmarks of cancer: a long noncoding RNA point of view［J］. RNA Biol, 2012, 9(6): 703-719. DOI: 10.4161/rna.20481. ［20］ Kallen AN, Zhou XB, Xu J, et al. The imprinted H19 lncRNA antagonizes let7 microRNAs［J］. Mol Cell, 2013, 52(1): 101-112. DOI: 10.1016/j.molcel.2013.08.027. ［21］ Wang F, Yuan JH, Wang SB, et al. Oncofetal long noncoding RNA PVT1 promotes proliferation and stem celllike property of hepatocellular carcinoma cells by stabilizing NOP2［J］. Hepatology, 2014, 60(4): 1278-1290. DOI: 10.1002/hep.27239. ［22］ Li SP, Xu HX, Yu Y, et al. LncRNA HULC enhances epithelialmesenchymal transition to promote tumorigenesis and metastasis of hepatocellular carcinoma via the miR200a3p/ZEB1 signaling pathway［J ］. Oncotarget, 2016, 7（27）： 42431-42446. DOI: 10.18632/oncotarget.9883. ［23］ Deng L, Yang SB, Xu FF, et al. Long noncoding RNA CCAT1 promotes hepatocellular carcinoma progression by functioning as let7 sponge［J］. J Exp Clin Cancer Res, 2015, 34: 18. DOI: 10.1186/s1304601501367. ［24］ Fang L, Du WW, Yang X, et al. Versican 3′untranslated region (3′ UTR) functions as a ceRNA in inducing the development of hepatocellular carcinoma by regulating miRNA activity［J］. FASEB J, 2013, 27(3): 907-919. DOI: 10.1096/fj.12220905. ［25］ Zhao L, Li F, Taylor EW. Can tobacco use promote HCVinduced miR122 hijacking and hepatocarcinogenesis?［J］. Med Hypotheses, 2013, 80(2): 131-133. DOI: 10.1016/j.mehy.2012.11.009. ［26］ Memczak S, Jens M, Elefsinioti A, et al. Circular RNAs are a large class of animal RNAs with regulatory potency［J］. Nature, 2013, 495(7441): 333-338. DOI: 10.1038/nature11928. ［27］ Shang X, Li G, Liu H, et al. Comprehensive circular RNA profiling reveals that hsa_circ_0005075, a new circular RNA biomarker, is involved in hepatocellular crcinoma development［J］. Medicine (Baltimore), 2016, 95 (22): e3811. DOI: 10.1097/MD.0000000000003811. ［28］ Esposito F, De Martino M, Petti MG, et al. HMGA1 pseudogenes as candidate protooncogenic competitive endogenous RNAs［J］. Oncotarget, 2014, 5(18): 8341-8354. DOI: 10.18632/oncotarget.2202. ［29］ Cheng DL, Xiang YY, Ji LJ, et al. Competing endogenous RNA interplay in cancer: mechanism, methodology, and perspectives［J］. Tumour Biol, 2015, 36(2): 479-488. DOI: 10.1007/s132770153093z.

[1]	Chen Hongjian, Zhang Suqing. Study on the relationship between serum miR-24-3p， H2AFX and clinical pathological features and postoperative recurrence in liver cancer patients [J]. Journal of International Oncology, 2024, 51(6): 344-349.
[2]	Peng Qin, Cai Yuting, Wang Wei. Advances on KPNA2 in liver cancer [J]. Journal of International Oncology, 2024, 51(3): 181-185.
[3]	Gong Yan, Chen Honglei. Research progress on the mechanism of microRNA regulation of cisplatin resistance in ovarian cancer [J]. Journal of International Oncology, 2024, 51(3): 186-190.
[4]	Sun Guobao, Yang Qian, Zhuang Qingchun, Gao Binbin, Sun Xiaogang, Song Wei, Sha Dan. Research progress on the histopathological growth patterns of colorectal liver metastasis [J]. Journal of International Oncology, 2024, 51(2): 114-118.
[5]	Xiang Yuling, Tan Jiajie, Xiong Yuanguo, Zhao Lirong, Li Chen, Zhang Hong. Effects of Anhydroicaritin on the proliferation， migration and apoptosis of hepatocellular carcinoma cells [J]. Journal of International Oncology, 2023, 50(9): 513-519.
[6]	Quan Zhenhao, Xu Feipeng, Huang Zhe, Huang Xianjin, Chen Rihong, Sun Kaiyu, Hu Xu, Lin Lin. lncRNA FTX silencing inhibits gastric cancer cell proliferation through the miR-22-3p/NLRP3 inflammasome pathway [J]. Journal of International Oncology, 2023, 50(4): 202-207.
[7]	Li Jiaxuan, Feng Yinglu. Mechanism of action of glucocorticoid receptors in the growth of hepatoma cells [J]. Journal of International Oncology, 2023, 50(4): 241-243.
[8]	He Ting, Wang Xi, Zhang Huizhong, Liu Xinyang, Wang Huiping, Dong Ke. Diagnostic value of serum TIM-3 in patients with liver cancer [J]. Journal of International Oncology, 2022, 49(9): 537-542.
[9]	Zhou Renbang, Zhang Zhongchuan, Xu Zhiyuan, Zhu Xunbing. MiR-219a-5p inhibits the proliferation, invasion and migration of osteosarcoma U2OS cells by negatively regulating HMGA2 [J]. Journal of International Oncology, 2022, 49(4): 193-198.
[10]	Jin Jiahui, Chen Cunhai, Ma Xuezhen. Effects of radiation-associated miRNA in radiotherapy for breast cancer [J]. Journal of International Oncology, 2022, 49(12): 735-738.
[11]	Jing Wenjun, Zhao Wenwen, Feng Qingqing, Zhao Wenfei, Zhao Lili, Zhang Xue, Wei Hongmei. Molecular basis and clinical prospect of the miR-34 family for the treatment of gastric cancer [J]. Journal of International Oncology, 2022, 49(11): 681-686.
[12]	Zhang Yumin, Zhao Xianwei, He Qianjin, Chen Jieneng. Value of contrast-enhanced ultrasound combined with serum CXCL8 and CXCR2 in the evaluation of postoperative efficacy of transcatheter arterial chemoembolization for primary liver cancer [J]. Journal of International Oncology, 2022, 49(10): 592-596.
[13]	Di Weihua, Zhao Xuemei. Research progress on the relationship between DNA damage repair genes and liver cancer [J]. Journal of International Oncology, 2022, 49(10): 635-638.
[14]	Luo Liyun, Lai Canhui, Liang Renpei, Yang Aiwu, Lin Zhimin. Correlation between the expressions of miR-524-5p and SOX9 in advanced gastric cancer and their influences on chemotherapy efficacy and prognosis [J]. Journal of International Oncology, 2022, 49(1): 45-50.
[15]	Hong Anlan, Cao Meng, Wang Yan, Fang Fang. Research progress on lncRNAs as members of ceRNA network in melanoma [J]. Journal of International Oncology, 2022, 49(1): 61-64.

Research progress of the competing endogenous RNA in primary hepatocellular carcinoma

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments